Virus Filtration Global Market Report 2026

Virus filtration is a method employed to physically remove potential viruses from manufacturing process streams, serving as a crucial step in ensuring the purity of medicines. These filters act as a primary defense against the introduction of adventitious viruses into this important category of pharmaceuticals. What sets virus filters apart is that their manufacturers have rigorously evaluated and optimized their robustness and efficiency in virus removal performance. Additionally, they have developed integrity tests correlated to virus removal.

The main types of virus filtration include kits and reagents, services, filtration systems, and other related categories. Kits are sterile tubing systems designed for the transfer of radioactive proteins between a labeling (reaction) vessel and a purification column, facilitated by peristaltic pumps. Reagents, on the other hand, are substances or compounds that can facilitate a reaction, and they find wide application in various tests. In the context of virus filtration, reagents are integral components of test kits. The use of virus filtration extends across pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and medical device companies. Its applications span diverse areas such as medical devices, water purification, air purification, biologicals, vaccines and therapeutics, blood and blood products, as well as cellular and gene therapy products.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have affected the virus filtration market by increasing the cost of imported membranes, filtration housings, testing reagents, and specialized consumables. Filtration systems and kits are most impacted, particularly in North America and Europe. Higher costs have influenced procurement strategies for biopharma companies. At the same time, tariffs have encouraged regional manufacturing of filtration components and strengthened local supply chains.

The virus filtration market research report is one of a series of new reports from The Business Research Company that provides virus filtration market statistics, including virus filtration industry global market size, regional shares, competitors with a virus filtration market share, detailed virus filtration market segments, market trends and opportunities, and any further data you may need to thrive in the virus filtration industry. This virus filtration market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The virus filtration market size has grown rapidly in recent years. It will grow from $5.94 billion in 2025 to $6.68 billion in 2026 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to growth in biologics manufacturing, regulatory focus on viral safety, expansion of vaccine production, increased outsourcing to CROs, adoption of advanced filtration technologies.

The virus filtration market size is expected to see rapid growth in the next few years. It will grow to $10.81 billion in 2030 at a compound annual growth rate (CAGR) of 12.8%. The growth in the forecast period can be attributed to growth in cell and gene therapies, expansion of biomanufacturing capacity, stricter regulatory standards, rising biologics pipeline, demand for contamination free production. Major trends in the forecast period include rising demand for biopharmaceutical safety, expansion of gene and cell therapy manufacturing, growing adoption of single use filtration systems, increased focus on process validation, rising use in vaccine production.

The increasing number of chronic diseases is expected to support the growth of the virus filtration market. Chronic diseases are long-term conditions that require ongoing medical attention or limit daily activities. Virus filtration helps reduce the risk of infectious and chronic diseases by effectively removing viruses during the production of biological and medical products. For example, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research organization, reported that more than half a billion people worldwide were living with diabetes, with projections indicating the number could rise to 1.3 billion by 2050. Therefore, the growing prevalence of chronic diseases is driving demand for virus filtration technologies.

The increasing demand within the pharmaceutical industry is also expected to drive the virus filtration market. The pharmaceutical industry conducts research, development, production, and marketing of medications and therapies. Virus filtration plays a crucial role in manufacturing biopharmaceuticals, vaccines, and advanced therapies, ensuring that products are safe, effective, and free from viral contaminants. For instance, in May 2024, IQVIA Inc., a US-based pharmaceutical analytics company, reported that U.S. medicine spending reached $435 billion at net price levels in 2023. By 2028, net spending is projected to grow by $127 billion, driven by increased medicine usage and adoption of innovative therapies, though partially offset by lower prices resulting from patent expiries and regulatory changes. Therefore, the growing pharmaceutical sector is contributing to the expansion of the virus filtration market.

Major companies in the virus filtration market are focusing on next-generation high-flux filtration technologies to improve bioprocess efficiency, increase throughput, and maintain robust viral safety. High-flux filtration allows liquids to pass through membranes at faster rates while preserving separation performance, reducing processing time and improving productivity. For example, in October 2024, Asahi Kasei Medical, a Japan-based chemical company, introduced Planova FG1, a next-generation virus removal filter aimed at improving biopharmaceutical manufacturing efficiency. Planova FG1 provides approximately seven times higher flux than the company's BioEX model, significantly reducing filtration time while maintaining strong viral removal performance-even during process interruptions. Early evaluations showed high protein recovery and consistent results without requiring prefiltration. Designed to be compatible with standard CIP and SIP systems, FG1 integrates easily into existing production setups. The product line will continue to expand to support rising global demand for biopharmaceuticals.

Major companies operating in the virus filtration market are Merck & Company Inc., GE Healthcare, Thermo Fisher Scientific Inc., Lonza Group Ltd., Pall Corporation, Charles River Laboratories International Inc., Sartorius AG, Asahi Kasei Medical Co. Ltd., WuXi AppTec, Danaher Corporation, Sigma-Aldrich Corporation, Pendotech, Purafil Inc., Parker Hannifin Corporation, Eaton Corporation, Freudenberg Group, Entegris Inc., Meissner Filtration Products Inc., Koch Membrane Systems Inc., Graver Technologies LLC, Amazon Filters Ltd., Cobetter Filtration Equipment Co. Ltd., Sterlitech Corporation, Membrane Solutions LLC, Advantec MFS Inc., GVS Group, Porvair Filtration Group

North America was the largest region in the virus filtration market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the virus filtration market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the virus filtration market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The virus filtration market consists of revenues earned by entities by providing virus filtering services to effectively remove viruses in various processes. The market value includes the value of related goods sold by the service provider or included within the service offering. The virus filtration market also includes sales of filters and systems used to remove viruses. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Virus Filtration Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses virus filtration market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for virus filtration ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The virus filtration market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product Type: Virus Filtration Devices; Virus Filtration Consumables; Virus Filtration Systems; Virus Filtration Services
• 2) By Filtration Technology: Size-Exclusion Virus Filtration; Membrane-Based Virus Filtration; Hollow Fiber Virus Filtration; Flat-Sheet Virus Filtration
• 3) By Application: Monoclonal Antibodies; Recombinant Proteins; Vaccines; Blood and Plasma-Derived Products; Cell and Gene Therapy Products; Other Biologic Therapeutics
• 4) By End User: Pharmaceutical Companies; Biotechnology Companies; Contract Development and Manufacturing Organizations (CDMOs); Contract Research Organizations
• Subsegments:
• 1) By Virus Filtration Devices: Single-Use Virus Filters; Reusable Virus Filters
• 2) By Virus Filtration Consumables: Virus-Rated Filter Cartridges; Virus-Rated Filter Capsules; Integrity Testing Accessories
• 3) By Virus Filtration Systems: Stand-Alone Virus Filtration Skids; Integrated Bioprocessing Filtration Systems
• 4) By Virus Filtration Services: Virus Clearance Validation Services; Filter Integrity Testing Services; Virus Removal Study Services
• Companies Mentioned: Merck & Company Inc.; GE Healthcare; Thermo Fisher Scientific Inc.; Lonza Group Ltd.; Pall Corporation; Charles River Laboratories International Inc.; Sartorius AG; Asahi Kasei Medical Co. Ltd.; WuXi AppTec; Danaher Corporation; Sigma-Aldrich Corporation; Pendotech; Purafil Inc.; Parker Hannifin Corporation; Eaton Corporation; Freudenberg Group; Entegris Inc.; Meissner Filtration Products Inc.; Koch Membrane Systems Inc.; Graver Technologies LLC; Amazon Filters Ltd.; Cobetter Filtration Equipment Co. Ltd.; Sterlitech Corporation; Membrane Solutions LLC; Advantec MFS Inc.; GVS Group; Porvair Filtration Group
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.